QA: NexImmune Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001538210_2023_NexImmune_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001538210, NexImmune Inc.

  xvar xval
0 AssetsCurrent 37,368,751
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,459,071
3 remainder_Assets 1,232,002
4 LiabilitiesCurrent 10,333,574
5 LiabilitiesNoncurrent 425,766
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,934,439
9 ResearchAndDevelopmentExpense 47,148,450
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 576,690
13 remainder_ComprehensiveNetIncome -3,012
  yvar yval
0 Assets 43,059,824
1 Liabilities 10,759,340
2 Expenses 63,082,889
3 Revenues 0
4 StockholdersEquity 32,300,484
5 NetIncome -62,506,199
6 ComprehensiveNetIncome -62,507,705
7 BaseVar 58,740,878
8 EconomicCapitalRatio -0.258

Edgar->Model Mapping

Feature Distribution

Change over Time